Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...

The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings compared with traditional methods.

Medtronic plc’s diabetes unit posted another win with the U.S. FDA approval of the Simplera continuous glucose monitoring sensor for use with the Minimed 780G pump system, helping the company catch up ...

Abbott recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 CGM systems.

Two endocrinologists who live with type 1 diabetes debate this issue at the Advanced Technologies & Treatments for Diabetes ...

The following is a summary of “Evidence for improved glucose metrics and perinatal outcomes with continuous glucose ...

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

The US FDA has granted approval for the use of Medtronic’s disposable Simplera Sync sensor with the MiniMed 780G system.

According to Yogish C. Kudva, Division of Endocrinology, Diabetes, Nutrition, Mayo Clinic, Rochester, Minnesota, USA, and ...

Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...